INNOVAHEALTH PARTNERS
INNOVAHEALTH PARTNERS is a Series C+ and buyout fund in the US, Europe and Israel investing in medical-devices and healthcare-tech.
- Stages
- Series C+, buyout
- Sectors
- medical-devices, healthcare-tech
- Invests in
- US-wide, Europe, Israel
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2016
- Assets under management
- $290M
- Website
- innovahealthpartners.com
Check size not disclosed
Thesis
InnovaHealth Partners is a private equity firm specializing in growth buyouts of established medical technology companies, with a strong emphasis on medical devices. They leverage proprietary research and deep industry expertise to identify and invest in companies poised for significant expansion. Their strategy centers on acquiring controlling positions, acting as the sole or lead investor, in companies with innovative products that address substantial unmet clinical needs. While not explicitly stated, their focus on 'growth buyouts' suggests a preference for companies in later stages of development (Series C and beyond) or established companies seeking capital for expansion. Geographically, they invest primarily in the United States, Europe, and Israel. The firm manages $290 million in assets under management and was founded in 2016. They partner closely with management teams to accelerate growth and create value.
Common questions
Does INNOVAHEALTH PARTNERS invest at the Series C+ stage?
Yes. INNOVAHEALTH PARTNERS lists Series C+ and buyout among the stages it invests in.
Where does INNOVAHEALTH PARTNERS invest?
INNOVAHEALTH PARTNERS invests in the US, Europe and Israel.